This podcast discusses the management of low-density lipoprotein cholesterol (LDL-C) and addresses the concept of when LDL-C levels are “low enough” to reduce the risk for atherosclerotic cardiovascular disease.

This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.

166456 11/21


Yehuda Handelsman, MD, FACP, FNLA, MACE

Medical Director & Principal Investigator
The Metabolic Institute of America